D-0619-2026 Class III Ongoing
FDA drug recall D-0619-2026 was initiated by ANI Pharmaceuticals, Inc. on Jun 2, 2026 and is designated Class III. Reason for recall: Presence of foreign substance The recall status is ongoing. Affected quantity: 6564 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2026
- Initiation Date
- Jun 2, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6564 bottles
Product description
hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10
Reason for recall
Presence of foreign substance
Distribution pattern
Nationwide in the USA
Code information
Lot S25133A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0619-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026